Last €127.49 EUR
Change Today -1.28 / -0.99%
Volume 10.0
ILU On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 9:32 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

illumina inc (ILU) Snapshot

Open
€126.55
Previous Close
€128.77
Day High
€128.77
Day Low
€125.89
52 Week High
07/2/14 - €135.90
52 Week Low
10/9/13 - €54.60
Market Cap
16.4B
Average Volume 10 Days
223.9
EPS TTM
--
Shares Outstanding
128.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ILLUMINA INC (ILU)

illumina inc (ILU) Details

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company’s products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

3,000 Employees
Last Reported Date: 02/18/14
Founded in 1998

illumina inc (ILU) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.1M
President and Director
Total Annual Compensation: $153.5K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $447.7K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $457.1K
Senior Vice President of Corporate Developmen...
Total Annual Compensation: $449.6K
Compensation as of Fiscal Year 2013.

illumina inc (ILU) Key Developments

Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, Enter Agreements with Illumina to Expand Access for Non-Invasive Prenatal Testing Across Europe

Illumina Inc. announced that it has entered into separate agreements with Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, under which they will use the HiSeq 2500 and consumables from Illumina to develop and perform non-invasive prenatal testing (NIPT). Biomnis plans to make NIPT available in France, Genoma plans to perform NIPT services in Italy, and the Center for Human Genetics and Laboratory Diagnostics will offer NIPT in Germany.

CareDx, Inc. and Illumina, Inc. Enter into Supply Agreement for Next Generation Sequencing Technologies

CareDx Inc. announced that it has entered into a multi-year supply agreement with Illumina Inc. that will provide access to next generation sequencing, microarray equipment and consumables to the CareDx reference and R&D laboratories.

Illumina Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 09:20 AM

Illumina Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 09:20 AM. Venue: Terranea Resort in Rancho Palos Verdes, 100 Terranea Way, Los Angeles, California, United States. Speakers: Jason T. Flatley, Chief Executive Officer and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILU:GR €127.49 EUR -1.28

ILU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Agilent Technologies Inc $56.60 USD +0.11
Avago Technologies Ltd $73.20 USD +0.05
Becton Dickinson and Co $119.36 USD +0.49
QIAGEN NV €18.05 EUR +0.209
Waters Corp $102.80 USD +0.61
View Industry Companies
 

Industry Analysis

ILU

Industry Average

Valuation ILU Industry Range
Price/Earnings 100.0x
Price/Sales 15.0x
Price/Book 14.4x
Price/Cash Flow 92.8x
TEV/Sales 13.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit www.illumina.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.